Phase 2 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have read and signed a consent form before the trial begins, understand what the trial involves including possible side effects, and are willing to follow the trial's rules and restrictions.
- People aged between 18 and 75 years old (inclusive) at the time of signing the consent form, of any gender.
- Women who could become pregnant must have a negative pregnancy blood test result at the screening stage.
- People who have been diagnosed with type 2 diabetes for at least 6 months.
Who may not be able to join:
- People who have or have previously had any form of cancer.
- People with a known or suspected allergy or sensitivity to the study drug or similar products.
- People who have had a severe hypoglycemic episode (very low blood sugar requiring help from another person) within the 6 months before screening.
- People who have had acute heart failure, a heart attack, unstable chest pain (angina), or a stroke, or been hospitalised for coronary heart disease within the 6 months before screening.
- People who have taken part in another interventional clinical trial within 4 weeks before being enrolled into this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Transparency, Gan & Lee Pharmaceuticals.
Phone: 01056456746
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.